Tracon Pharma

Developer of antibody therapeutics for the treatment of cancer and fibrotic diseases

placeSan Diego, California, United States calendar_todayFounded 2005 groups17 employees language traconpharma.com

Registered entities

Investor mix

11 investors on record; lead investors include Icon Ventures, New Enterprise Associates; 2 have since exited.

Investor typeCountShare
Venture capital545%
Private equity545%
Other / undisclosed19%
Coming soon